how does semaglutide reduce cardiovascular risk Research shows — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people with some chronic diseases, even if they have heart issues. ✍️ Health Evaluating the Cardiovascular Benefits of

GLP-1s have been shown to impact multiple pathways involved in plaque formation, exhibiting atheroprotective effects. Whats important, the authors noted, is that since the pathophysiology of NAION is incompletely understood, there may be unaccounted factors that influence the relationship between these medications and this condition

In addition to lowering blood glucose, GLP-1 and its agonists activate receptors in the hypothalamus, a part of the brain that regulates appetite and food intake

A weak understanding about how the correlations between polyphenol intake and microbial changes can be translated in a huge causality in human health outcomes is still challenging (Scott et al., 2022b)

Accessed August 11, 2025.